1. |
Leek RD, Kaklamanis L, Pezzela F, et al. bcl2 in normal human breast and carcinoma,association with oestrogen receptorpositive, epidermal growth factor receptornegative tumors and in situ cancer. Br J Cancer, 1994; 69(1)∶135.
|
2. |
駱成玉, 詹新恩, 姜軍. 乳腺癌組織中T細胞亞群分布的觀察與分析. 中華實驗外科雜志, 1992; 9(增刊)∶219.
|
3. |
Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: laboratory manuals. 2th ed. New York: Cold Spring Harbor Laboratory Press, 1989∶463-493.
|
4. |
Yuan R, Dowling P, Zucca E, et al. Detection of bcl2/JH rearrangement in follicular and diffuse lymphoma: concordant results of peripheral blood and bone marrow analysis at diagnosis. Br J Cancer, 1993; 67(5)∶922.
|
5. |
Hsu B, Marin MC, Brisbay S, et al. Expression of bcl2 gene confers multidrug resistance to chemotherapyinduced cell death. Cancer Bull, 1994; 46(1)∶125.
|
6. |
Fisher TC, Milner AE, Gregory CD, et al. Bcl2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res, 1993; 53(15)∶3321.
|